# Intra-articular Transplantation of Autologous Adipose Derived Stromal Vascular Faction (SVF) for Treatment of Osteoarthritis of the Knee

> **NCT03940950** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 9 (actual)

## Conditions studied

- Osteo Arthritis Knee
- Degenerative Joint Disease of Knee

## Interventions

- **BIOLOGICAL:** Autologous Adipose-Derived SVF (Stromal Vascular Fraction)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03940950
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-02
- **Primary completion:** 2025-05-05
- **Final completion:** 2025-05-23
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2026-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03940950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03940950, "Intra-articular Transplantation of Autologous Adipose Derived Stromal Vascular Faction (SVF) for Treatment of Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03940950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*